Allogene Therapeutics, Inc. SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of...
Dyadic International, Inc. JUPITER, Fla., July 30, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic,” “we,” “our” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused...
Nanobiotix SA PARIS and CAMBRIDGE, Massachusetts, May 22, 2024 (GLOBE NEWSWIRE) – NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ”Company”), an advanced clinical-stage biotechnology company...
